Northwest Bioth Cmn (NWBO)

$0.26 +0.00 (1.65%)
Market Cap 405.51M
Revenue (ttm) 1.38M
Net Income (ttm) -83.78M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -6,071.01%
Debt to Equity Ratio 0.00
Volume 1,867,600
Avg Vol 3,407,590
Day's Range N/A - N/A
Shares Out 1.59B
Stochastic %K 28%
Beta -0.86
Analysts Strong Buy
Price Target $2.00

Company Profile

Northwest Biotherapeutics, Inc., a biotechnology company, focuses on developing personalized immune therapies for cancer. The company develops DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product candidate is the DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct, that has completed Phase I clinical trials to treat inop...

Industry: Biotechnology
Sector: Healthcare
Phone: 240 497 9024
Address:
4800 Montgomery Lane, Suite 800, Bethesda, United States
DeepThought
DeepThought Mar. 22 at 6:04 AM
$NWBO I appreciate your perspective, but reducing a structured analysis to ‘monotonic fact‑listing’ says more about your expectations than about the substance. Critical thinking isn’t about amplifying enthusiasm, it’s about understanding constraints. And anyone claiming that a dendritic‑cell vaccine could get FDA approval after a Phase I trial, especially without scalable, validated manufacturing, should seriously reconsider their understanding of regulatory science! That’s simply not how the FDA works, not even remotely. If that level of clarity feels too measured, perhaps the issue isn’t the analysis. If you’re truly 100% committed to NWBO, then it would be helpful to act like it. Longs strengthen each other by contributing clarity, not by repeatedly throwing out vague, disruptive questions that only undermine the discussion. Supporting the long position means elevating the conversation not weakening it!
0 · Reply
SodApOp_PIMPski_Rises
SodApOp_PIMPski_Rises Mar. 21 at 11:19 PM
$NWBO every bull here is a huge baggie, think about that📉📉
1 · Reply
Lookinglong
Lookinglong Mar. 21 at 10:39 PM
$NWBO Put up or shut up!! https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177421860
3 · Reply
wjmax
wjmax Mar. 21 at 8:15 PM
$NWBO I don't blame you. You are just a limited factor interpreter. You need to be a fact digestor with some critical thinking. I am over 100% for $NWBO. But I get bored with your monotic way of listing some facts. Enlighten me which part I said is crappy.
0 · Reply
DeepThought
DeepThought Mar. 21 at 7:50 PM
$NWBO Are you having a bot answer for you, or does that whole cloud of words come from you? All the crap you’re posting here makes absolutely no sense at all. What exactly are you trying to tell the world, and where do you even stand on NWBO?
1 · Reply
SodApOp_PIMPski_Rises
SodApOp_PIMPski_Rises Mar. 21 at 7:40 PM
$NWBO this penny punper must be danish duds new alt account
1 · Reply
wjmax
wjmax Mar. 21 at 6:38 PM
$NWBO My point is that at this stage you still cannot see how the DC vaccine programs at Mayo and Moffitt Cancer Center are connected to $NWBO. You don't think BPs can easily develop their DC vaccine manufacturing platform if they want to? Have you seen those symphony institutions filed various patents on DC vaccines? They didn't. Because their CORE technologies are most likely in-licensed from the third party. I suggest you scan the whole spectrum first before making meaningful predictions.
1 · Reply
DeepThought
DeepThought Mar. 21 at 5:49 PM
$NWBO Mayo and Moffitt run excellent academic programs, but they’re not building commercially scalable DC platforms. We are. FlaskWorks Eden gives us an automated, closed, GMP‑consistent process — something no manual academic workflow can compete with. BP doesn’t partner with whoever ran a Phase 1 first; they partner with whoever can actually industrialize the science. That’s the difference, and that’s exactly where we outperform! If you want to make a serious point, make one. Otherwise, save the commentary. I’m not here to entertain noise!
1 · Reply
Bullzballs
Bullzballs Mar. 21 at 5:01 PM
$NWBO The mm and shorts are at it again. They pushed this back down .01. Bastards . lol
0 · Reply
wjmax
wjmax Mar. 21 at 4:36 PM
$NWBO Have you seen the DC vaccine trials conducted by Mayo Clinic and Moffitt Cancer Center on various targets? Merck even struck a collaboration deal with Mayo Clinic. FDA is not going to fixate on the definition of phase. FDA is now concerned about the efficacy of treatment. If the treatment works, the approval can be granted even the treatment went through phase 1 trial. You think BPs will have interest in us while the trials from the two institutions have DC vaccine trials that already produced amazing results? https://clinicaltrials.gov/search?term=%22dendritic%20cell%22&spons=Mayo%20clinic&viewType=Card https://clinicaltrials.gov/search?term=%22dendritic%20cell%22&spons=Moffitt%20cancer%20center&viewType=Card
1 · Reply
Latest News on NWBO
No data available.
DeepThought
DeepThought Mar. 22 at 6:04 AM
$NWBO I appreciate your perspective, but reducing a structured analysis to ‘monotonic fact‑listing’ says more about your expectations than about the substance. Critical thinking isn’t about amplifying enthusiasm, it’s about understanding constraints. And anyone claiming that a dendritic‑cell vaccine could get FDA approval after a Phase I trial, especially without scalable, validated manufacturing, should seriously reconsider their understanding of regulatory science! That’s simply not how the FDA works, not even remotely. If that level of clarity feels too measured, perhaps the issue isn’t the analysis. If you’re truly 100% committed to NWBO, then it would be helpful to act like it. Longs strengthen each other by contributing clarity, not by repeatedly throwing out vague, disruptive questions that only undermine the discussion. Supporting the long position means elevating the conversation not weakening it!
0 · Reply
SodApOp_PIMPski_Rises
SodApOp_PIMPski_Rises Mar. 21 at 11:19 PM
$NWBO every bull here is a huge baggie, think about that📉📉
1 · Reply
Lookinglong
Lookinglong Mar. 21 at 10:39 PM
$NWBO Put up or shut up!! https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177421860
3 · Reply
wjmax
wjmax Mar. 21 at 8:15 PM
$NWBO I don't blame you. You are just a limited factor interpreter. You need to be a fact digestor with some critical thinking. I am over 100% for $NWBO. But I get bored with your monotic way of listing some facts. Enlighten me which part I said is crappy.
0 · Reply
DeepThought
DeepThought Mar. 21 at 7:50 PM
$NWBO Are you having a bot answer for you, or does that whole cloud of words come from you? All the crap you’re posting here makes absolutely no sense at all. What exactly are you trying to tell the world, and where do you even stand on NWBO?
1 · Reply
SodApOp_PIMPski_Rises
SodApOp_PIMPski_Rises Mar. 21 at 7:40 PM
$NWBO this penny punper must be danish duds new alt account
1 · Reply
wjmax
wjmax Mar. 21 at 6:38 PM
$NWBO My point is that at this stage you still cannot see how the DC vaccine programs at Mayo and Moffitt Cancer Center are connected to $NWBO. You don't think BPs can easily develop their DC vaccine manufacturing platform if they want to? Have you seen those symphony institutions filed various patents on DC vaccines? They didn't. Because their CORE technologies are most likely in-licensed from the third party. I suggest you scan the whole spectrum first before making meaningful predictions.
1 · Reply
DeepThought
DeepThought Mar. 21 at 5:49 PM
$NWBO Mayo and Moffitt run excellent academic programs, but they’re not building commercially scalable DC platforms. We are. FlaskWorks Eden gives us an automated, closed, GMP‑consistent process — something no manual academic workflow can compete with. BP doesn’t partner with whoever ran a Phase 1 first; they partner with whoever can actually industrialize the science. That’s the difference, and that’s exactly where we outperform! If you want to make a serious point, make one. Otherwise, save the commentary. I’m not here to entertain noise!
1 · Reply
Bullzballs
Bullzballs Mar. 21 at 5:01 PM
$NWBO The mm and shorts are at it again. They pushed this back down .01. Bastards . lol
0 · Reply
wjmax
wjmax Mar. 21 at 4:36 PM
$NWBO Have you seen the DC vaccine trials conducted by Mayo Clinic and Moffitt Cancer Center on various targets? Merck even struck a collaboration deal with Mayo Clinic. FDA is not going to fixate on the definition of phase. FDA is now concerned about the efficacy of treatment. If the treatment works, the approval can be granted even the treatment went through phase 1 trial. You think BPs will have interest in us while the trials from the two institutions have DC vaccine trials that already produced amazing results? https://clinicaltrials.gov/search?term=%22dendritic%20cell%22&spons=Mayo%20clinic&viewType=Card https://clinicaltrials.gov/search?term=%22dendritic%20cell%22&spons=Moffitt%20cancer%20center&viewType=Card
1 · Reply
DeepThought
DeepThought Mar. 21 at 12:13 PM
$NWBO Why a Buyout of NWBO at Actelion‑Level (~$30B) Is Plausible! (Actelion was the largest single‑franchise biotech buyout in history) If DCVax‑L receives regulatory approval, NWBO becomes one of the purest single‑franchise buyout cases in biotech history. The logic is straightforward: - Single product (DCVax‑L) - Single indication (GBM) - Monopoly‑like market (no effective competitors) - High pricing power (oncology + cell therapy + orphan) - Platform potential (but undeveloped by NWBO → strategic upside for buyer) - Post‑approval status eliminates risk and maximizes valuation This combination makes a $20–40B buyout not only imaginable but structurally justified! Wishing you lots of fun and a wonderful weekend!
7 · Reply
SodApOp_PIMPski_Rises
SodApOp_PIMPski_Rises Mar. 21 at 12:04 PM
$NWBO next month is the new date🤭🤭😂😂🫵🫵
1 · Reply
Ttubular
Ttubular Mar. 21 at 12:04 PM
$NWBO will NWBO get their DVX approved in year 3 or do we move to year 4 n hope again. As far as I’m concerned this is absolutely ridiculous. They have RWD for a long time that it works saves limes prolongs life. So what is MHRA problem? I’m long n strong but NWBO brings a new meaning to long n strong. 💪
0 · Reply
BunMac
BunMac Mar. 21 at 10:10 AM
$NWBO https://obits.nj.com/us/obituaries/trenton/name/todd-willever-obituary?id=60992739&utm_source=webshareapi&utm_medium=share_button&utm_campaign=wsapimobile_beta
0 · Reply
bigbigwin
bigbigwin Mar. 21 at 6:44 AM
$NWBO p.2
0 · Reply
bigbigwin
bigbigwin Mar. 21 at 6:43 AM
$NWBO
0 · Reply
bigbigwin
bigbigwin Mar. 21 at 4:16 AM
$NWBO Recently Advent hired many new staff and the building C, the revenue from advent would cover it? Or it will pass to new owner soon so no need big money? Nwbo will not attend ASCO this year. 😳
0 · Reply
SodApOp_PIMPski_Rises
SodApOp_PIMPski_Rises Mar. 21 at 3:54 AM
$NWBO the danish dud got arrested by the sec for pumping this boiler room scam
1 · Reply
willy2474
willy2474 Mar. 21 at 3:48 AM
$NWBO what happened yo Danish? i miss his fantasy stories
0 · Reply
SuperFunTime
SuperFunTime Mar. 21 at 2:54 AM
$NWBO what do you think George means in this email to me when he says “they still haven’t made a decision yet”? Does this shutdown the “we are approved and waiting for labeling”?
2 · Reply
SodApOp_PIMPski_Rises
SodApOp_PIMPski_Rises Mar. 21 at 2:52 AM
$NWBO fresh downgrade🤭🤭📉📉⚰️⚰️
4 · Reply
Jjscans
Jjscans Mar. 21 at 2:37 AM
$NWBO
1 · Reply